Effect of sutureless securement on hemodialysis catheter-related bloodstream infection.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 11 2021
Historique:
received: 28 05 2021
accepted: 27 10 2021
entrez: 6 11 2021
pubmed: 7 11 2021
medline: 27 1 2022
Statut: epublish

Résumé

The use of sutureless securement devices during catheterization might reduce the risk of catheter-related bloodstream infection (CRBSI) by suppressing catheter-exit infection and catheter dislodgement. However, the effectiveness of these devices in reducing CRBSI risk when securing hemodialysis catheters has not been explored. This single-center retrospective observational study examined 211 non-tunneled hemodialysis catheters (NTHCs) from 110 hemodialysis inpatients, of which 121 were secured using conventional skin sutures (Suture group) and 90 with GRIP-LOK (GRIP-LOK group). The stabilized inverse probability of treatment (SIPT)-weighting method was used to generate a new population (SIPT-weighted model) without group differences for each of the 12 predictors of CRBSI development (i.e., age, sex, dialysis history, concomitant acute kidney injury or diabetes, concurrent use of immunosuppressant drugs or aspirin, NTHC insertion site, methicillin-resistant Staphylococcus aureus, carriage, bacteremia event within 3 months before catheterization, hemoglobin level, and serum albumin titer). The effect of GRIP-LOK compared with sutures on CRBSI in the SIPT-weighted model was evaluated using univariate SIPT-weighted Cox proportional regression analysis, which showed a significant CRBSI suppression effect of GRIP-LOK compared with sutures (hazard ratio: 0.17 [95% CI 0.04-0.78], p = 0.023). GRIP-LOK affords a lower risk of CRBSI due to indwelling NTHCs than conventional securement using sutures.

Identifiants

pubmed: 34741127
doi: 10.1038/s41598-021-01372-6
pii: 10.1038/s41598-021-01372-6
pmc: PMC8571352
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21771

Subventions

Organisme : the Japan Society for the Promotion of Science
ID : no. 18K15988

Informations de copyright

© 2021. The Author(s).

Références

BMC Nephrol. 2019 May 31;20(1):199
pubmed: 31151433
Expert Rev Clin Pharmacol. 2008 May 1;1(3):391-400
pubmed: 19829754
Intensive Care Med. 2004 Jan;30(1):62-7
pubmed: 14647886
Clin J Am Soc Nephrol. 2009 Aug;4(8):1388-400
pubmed: 19590063
Kidney Int. 2000 May;57(5):2151-5
pubmed: 10792637
J Am Soc Nephrol. 1998 May;9(5):869-76
pubmed: 9596085
Crit Care Med. 2005 Jan;33(1):13-20; discussion 234-5
pubmed: 15644643
Nephrol Dial Transplant. 2016 Feb;31(2):298-305
pubmed: 26666499
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Kidney Int. 2000 Oct;58(4):1758-64
pubmed: 11012910
Am J Med. 1991 Sep 16;91(3B):197S-205S
pubmed: 1928165
N Engl J Med. 1977 Jun 9;296(23):1305-9
pubmed: 323710
Clin Infect Dis. 2009 Jul 1;49(1):1-45
pubmed: 19489710
Clin Infect Dis. 2011 May;52(9):e162-93
pubmed: 21460264
J Infect Public Health. 2017 Jul - Aug;10(4):403-408
pubmed: 27423929
BMC Med Res Methodol. 2017 Jul 10;17(1):93
pubmed: 28693428
Nephron. 2002 Jul;91(3):399-405
pubmed: 12119469
Intensive Care Med. 2002 Jan;28(1):18-28
pubmed: 11818995
Am J Infect Control. 1996 Aug;24(4):262-77
pubmed: 8870910
J Vasc Access. 2021 May;22(3):337-343
pubmed: 32648807
Anaesthesia. 2008 May;63(5):559-60
pubmed: 18412669
Am J Infect Control. 2013 Feb;41(2):118-21
pubmed: 22748842
J Vasc Interv Radiol. 2002 Jan;13(1):77-81
pubmed: 11788698
Nephrol Dial Transplant. 2015 Jun;30(6):1028-37
pubmed: 25637641
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Kidney Int. 1999 Mar;55(3):1081-90
pubmed: 10027947
Br J Nurs. 2020 Apr 23;29(8):S28-S33
pubmed: 32324466
Am J Kidney Dis. 2007 Mar;49(3):401-8
pubmed: 17336701
Am J Kidney Dis. 2001 Jun;37(6):1232-40
pubmed: 11382693
Kidney Int. 2004 Dec;66(6):2429-36
pubmed: 15569336

Auteurs

Keiji Fujimoto (K)

Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan. k-2210@kanazawa-med.ac.jp.

Emi Iida (E)

Blood Purification Center, Kanazawa Medical University Hospital, Uchinada, Ishikawa, Japan.
Nursing Services Division, Kanazawa Medical University Hospital, Uchinada, Ishikawa, Japan.

Syo Kumano (S)

Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.

Ai Fujii (A)

Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.

Hiroki Adachi (H)

Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Blood Purification Center, Kanazawa Medical University Hospital, Uchinada, Ishikawa, Japan.

Kengo Furuichi (K)

Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.
Blood Purification Center, Kanazawa Medical University Hospital, Uchinada, Ishikawa, Japan.

Hitoshi Yokoyama (H)

Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH